Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type | Therapeutic or Technology | Institution | Stage | Project Objective | Details |
---|---|---|---|---|---|---|
Traumatic Brain Injury | Embryonic Stem Cell | Exosomes based therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept, Research Insights | |
HIV/AIDS, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Spina Bifida | Adult Stem Cell | Donor cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | Boston Children's Hospital |
![]() |
Clinical Trial, Phase 2 | |
Beta Thalassemia, Sickle Cell Disease |
Adult Stem Cell | Diagnostic Test | UCSF |
![]() |
Regulated Lab Test, Ready for Validation | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Antibody | Immune-Onc Therapeutics |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Multiple Myeloma | Adult Stem Cell | Gene-modified, donor cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Melanoma | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Amyotrophic Lateral Sclerosis | Adult Stem Cell | Gene-modified, donor cell therapy | Cedars-Sinai |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Stroke | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Heart failure | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Heart Disease | iPS Cell | Donor cell therapy | UC Davis |
![]() |
Development Candidate, Proof of Concept | |
Pancreatic Cancer | Cancer Stem Cell | Small molecule therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Liver Disease | iPS Cell | Diagnostic Test | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Brain Cancer, Neurological Disorders |
Embryonic Stem Cell | Exosomes based therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept | |
Anemia |
Adult Stem Cell, iPS Cell |
Small molecule therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Heart failure | iPS Cell | Exosomes based therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Angelman Syndrome, Autism |
iPS Cell | Gene Therapy, cell free | UC Davis |
![]() |
Development Candidate, Proof of Concept | |
Epidermolysis Bullosa | iPS Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Ovarian Cancer | iPS Cell | Gene-modified, donor cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Amyotrophic Lateral Sclerosis | Adult Stem Cell | Donor cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Heart Disease | iPS Cell | Model system development | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
B cell cancers, Leukemia, Leukemia, Acute Myeloid (AML) |
Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Cartilage defect | Embryonic Stem Cell | Donor cell therapy | USC |
![]() |
IND | |
Blood Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
IND | |
Muscular Dystrophy | Protein/peptide therapy | Juvena Therapeutics Inc. |
![]() |
Pre-IND/IDE or Equivalent | ||
Stroke | iPS Cell | Donor cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Heart Disease | Adult Stem Cell | Antibody | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
IPEX Syndrome | Adult Stem Cell | Gene-modified, personalized cell therapy | ImmunoVec |
![]() |
Pre-IND/IDE or Equivalent | |
Brain Cancer | Somatic Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Pre-IND/IDE or Equivalent | |
Heart Disease | iPS Cell | Protein/peptide therapy | Regencor, Inc. |
![]() |
Pre-IND/IDE or Equivalent | |
Metabolic Disorders | Somatic Cell | Gene-modified, personalized cell therapy | Immusoft Corporation |
![]() |
Pre-IND/IDE or Equivalent | |
Duchenne Muscular Dystrophy | Somatic Cell | Gene Therapy, cell free | MyoGene Bio LLC |
![]() |
Pre-IND/IDE or Equivalent | |
B cell cancers | Somatic Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Pre-IND/IDE or Equivalent | |
Spinal Cord Injury | Adult Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Heart Disease | iPS Cell | Model system development | Organos, Inc. |
![]() |
Tool/Resources/Bottleneck | |
Heart failure | Adult Stem Cell | Nucleic acid based therapy | Cedars-Sinai |
![]() |
Development Candidate, Proof of Concept | |
Neurological Disorders | iPS Cell | Gene Therapy, cell free | Navega Therapeutics |
![]() |
Development Candidate, Proof of Concept | |
Spinal Cord Injury | iPS Cell | Other Components | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Multiple Myeloma | Somatic Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Multiple Sclerosis | Adult Stem Cell | Small molecule therapy | Scripps |
![]() |
Development Candidate, Proof of Concept | |
Kidney Disease | Somatic Cell | Gene Therapy, cell free | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Neurological Disorders, Sanfilippo Syndrome/MPS III |
iPS Cell | Gene-modified, personalized cell therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept | |
Huntington's Disease | iPS Cell | Gene Therapy, cell free | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Cartilage defect | Adult Stem Cell | Biologic | The Stone Research Foundation for Sports Medicine and Arthritis |
![]() |
Development Candidate, Proof of Concept | |
Cartilage defect, Osteoarthritis |
Embryonic Stem Cell | Donor cell therapy | Scripps Health |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes |
Embryonic Stem Cell, iPS Cell |
Biologic | UCLA |
![]() |
Development Candidate, Proof of Concept |